Business
Theravance Biopharma to Participate in the 6th Annual Evercore ISI HealthCONx Conference
DUBLIN, Nov. 15, 2023 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will participate in a Fireside Chat at the 6th Annual Evercore ISI HealthCONx
About this update from Theravance Biopharma, Inc.
[{"type":"text","content":"DUBLIN, Nov. 15, 2023 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will participate in a Fireside Chat at the 6th Annual Evercore ISI HealthCONx Conference Tuesday, November 28 at 1:45 pm EST (10:45 am PST/6:45 pm GMT) and will be hosting in-person meetings with the investment community at the conference.\n\n \n \n \n \n \n \n\n \nA Webcast of the event may be accessed by visiting Theravance.com, under the Investors section: Presentations and Events. A Replay of the webcast will be archived on the Company's website for 30 days.\nAbout Theravance Biopharma \nTheravance Biopharma, Inc.'s focus is to deliver Medicines that Make a Difference® in people's lives. In pursuit of its purpose, Theravance Biopharma leverages decades of expertise, which has led to the development of FDA-approved YUPELRI® (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Ampreloxetine, its late-stage investigational norepinephrine reuptake inhibitor in development for symptomatic neurogenic orthostatic hypotension, has the potential to be a first in class therapy effective in treating a constellation of cardinal symptoms in multiple symptom atrophy patients. The Company is committed to creating/driving shareholder value.\nFor more information, please visit www.theravance.com.\nTHERAVANCE BIOPHARMA®, THERAVANCE®, and the Cross/Star logo are registered trademarks of the Theravance Biopharma group of companies (in the U.S. and certain other countries).\nYUPELRI® is a registered trademark of Mylan Specialty L.P., a Viatris company. Trademarks, trade names or service marks of other companies appearing on this press release are the property of their respective owners.\nContact:[email protected]\n \n\n View original content to download multimedia:https://www.prnewswire.com/news-releases/theravance-biopharma-to-participate-in-the-6th-annual-evercore-isi-healthconx-conference-301988516.html\nSOURCE THERAVANCE BIOPHARMA US, INC.","length":4058,"tagName":"div"}]